If you are interested in participating in a clinical trial, please visit our Contact Us Page.
Our research program includes both NIH-funded and commercially sponsored clinical studies. We offer both observational studies and interventional pharmaceutical studies. Our current focus is in these therapeutic areas:
NASH/fatty liver disease:
-Our NASH program includes studies as part of the NIDDK-sponsored NASH CRN Database study and a clinical trial examining various doses of vitamin E for NAFLD/NASH (VEDS).
-We also offer commercially sponsored therapeutic trials based on both non-invasive tests (MRI, MR) and liver biopsy as endpoints.
-A number of trials are available for patients with all stages of fibrosis ranging from NASH without fibrosis (scarring) to NASH with compensated cirrhosis.
Primary biliary cholangitis (PBC):
-We have ongoing Phase 3 and Phase 2 studies of novel therapeutic agents for treatment of PBC
Primary sclerosing cholangitis (PSC):
-We have several ongoing Phase 2 and Phase 3 trials for PSC
Chronic hepatitis B:
-We currently have an ongoing clinical trial for patients with immune-tolerant chronic hepatitis B
If you are interested in participating in a clinical trial, please Contact Our Office.
Some Excellent Resources:
Globe PBC: https://www.globalpbc.com/globe
NAFLD Simulator: https://www.nafldsimulator.org/
Fatty Liver Index: https://www.mdcalc.com/fatty-liver-index
PubMed citations: https://www.ncbi.nlm.nih.gov/pubmed/?term=kowdley+k
Google h-index: 92; https://scholar.google.com/citations?user=5roV7_AAAAAJ&hl=en